HOME >> BIOLOGY >> NEWS
Wake Forest Physicians Demonstrate How Gene-Diet Interaction Affects Cholesterol Absorption

WINSTON-SALEM, N.C. -- Physicians at Wake Forest University Baptist Medical Center reported today the first demonstration of a gene-diet interaction that affects the absorption of cholesterol in humans.

Richard B. Weinberg, M.D., professor of internal medicine and head of the section on gastroenterology reported at the American Heart Association meeting that the demonstration could eventually pave the way for individualized diet prescriptions.

For several years, Weinberg has been studying a common genetic variant of a standard protein in the blood that appears to protect the people who have it from excess dietary cholesterol.

In the current study, Weinberg and his colleagues reported, "The amount of cholesterol our subjects absorbed was controlled by the type of fat in the diet and whether or not they carried the variant gene. Subjects with the apo A-IV-2 (the scientific name for the variant gene) absorbed much less cholesterol than the 'normal' subjects."

He said about 15 percent of the population carry the apo A-IV-2 gene; most of the rest have the apo-A-IV-1 gene. In the current study, the subjects, mostly medical students and staff members of the Wake Forest University Baptist Medical Center, were tested with three high cholesterol diets, varying the amounts of saturated fat or polyunstaurated fat.

The investigators compared people with the normal gene to people with the variant gene on each of the three diets.

One diet had 35 percent of the daily calories from fat, and 15 percent of total calories were from saturated fat. The second diet also had 35 percent of the calories from fat, and 15 percent of total calories from polyunsaturated fat. The third high-cholesterol diet was low fat, with only 20 percent of the calories from fat, and the fat was made up of equal amounts of saturated fat, polyunsaturated fat (such as vegetable oil) and monounsaturated fat (such as olive oil).


'"/>

Contact: Robert Conn, Mark Wright or Jim Steele
rconn@wfubmc.edu
336-716-4587
Wake Forest University Baptist Medical Center
9-Nov-1998


Page: 1 2

Related biology news :

1. Forest managers can fight invasive species that come with roads
2. Forest fire sensor inspired by nature
3. Rutgers ecologists and Brooklyn Botanic Garden botanists to plan Beijing Olympics Forest Park
4. Virginia Tech and North Carolina State University to run Forest Nutrition Research Cooperative
5. Forest preservation work turns to Carolina hemlock
6. Nonnative Invasive Plants of Southern Forests
7. Wake Forest researcher identifies syndrome as leading cause of death in premature infants
8. Wake Forest scientists develop colony of mice that fight off virulent cancer
9. Forest fragmentation may increase Lyme disease risk
10. USDA Forest Service publishes wildland-urban interface assessment
11. Forests of the continental U.S. continue to fragment

Post Your Comments:
(Date:5/23/2013)... 23, 2013) A new report from the Institute ... pupils engage in at least 60 minutes of vigorous ... No more than half of American youth meet current ... or moderate intensity physical activity daily, according to the ... are in school for nearly half of their waking ...
(Date:5/23/2013)... In an age when microbial pathogens are growing increasingly ... infection, a team of Wisconsin scientists has synthesized a ... bacteria that cause staph infections. , Writing online in ... a group led by University of Wisconsin-Madison chemistry Professor ... "quorum sensing" behavior of Staphylococcus aureus , a ...
(Date:5/22/2013)... a major new effort to educate the public and ... with clean water that looms ahead in the 21st ... the current edition of Chemical & Engineering News ... (ACS), the world,s largest scientific society. , Bassam Z. ... Schnoor, Ph.D., explain that shortages of reliable supplies of ...
Breaking Biology News(10 mins):Schools should provide students with daily physical activity, IOM recommends 2University of Wisconsin chemists find new compounds to curb staph infection 2
(Date:5/23/2013)... , May 23, 2013 VG Energy, ... alliance with DAK Renewable Research to conduct field ... yield. VG Energy is a majority owned subsidiary ... VG Energy,s exclusively licensed compound LipidMax ... oil yield in plants, possessing a wide variety ...
(Date:5/23/2013)... EXTON, Pa. , May 23, 2013 /PRNewswire/ ... leading research and advisory firms for specialized biopharmaceutical ... gastroenterologists, hepatologists, and infectious disease specialists reported that ... warehousing patients (e.g., intentionally delaying treatment) in anticipation ... physicians than six months ago, when only 6 ...
(Date:5/23/2013)... Northwest Biotherapeutics (NASDAQ: NWBO ) ... personalized immune therapies for solid tumor cancers, announced today ... American Society Of Clinical Oncology (ASCO) meeting in ... in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ) ... pre-eminent conference focused on clinical treatment of cancer, with ...
(Date:5/23/2013)...  Verenium Corporation (Nasdaq: VRNM ), a ... commercialization of high-performance enzymes, today announced that ... at two upcoming conferences. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO ... Second Annual Marcum LLP Microcap Conference on Thursday, May ... York City.  The presentation is scheduled to begin at ...
Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3
Cached News: